Page last updated: 2024-12-06
chlorodifluoroacetic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
chlorodifluoroacetic acid: RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 66154 |
SCHEMBL ID | 132463 |
MeSH ID | M0197006 |
Synonyms (34)
Synonym |
---|
c2hclf2o2 |
nsc60298 |
acetic acid, chlorodifluoro- |
chlorodifluoroacetic acid |
76-04-0 |
nsc-60298 |
chlorodifluoroacetic acid, 98% |
C0990 |
2-chloro-2,2-difluoroacetic acid |
AKOS000119358 |
chloro(difluoro)acetic acid |
nsc 60298 |
einecs 200-928-8 |
ai3-52628 |
acetic acid, 2-chloro-2,2-difluoro- |
FT-0623642 |
S12286 |
SCHEMBL132463 |
difluorochloroacetic acid |
2-chloro-2,2-difluoro-acetic acid |
chlorodifluoro acetic acid |
DTXSID8058792 |
Q-102557 |
Z1270446583 |
F2191-0221 |
mfcd00004176 |
CS-W001107 |
chlorodifluoroaceticacid |
BCP24417 |
cdfa |
STR00299 |
AMY3628 |
pfca-cl; c2hclf2o2 |
EN300-20290 |
Research Excerpts
Overview
Chlorodifluoroacetic acid (CDFA) is a novel haloacetic Acid (HAA) and has been recently documented in aquatic systems.
Excerpt | Reference | Relevance |
---|---|---|
"Chlorodifluoroacetic acid (CDFA) is a novel haloacetic acid (HAA) and has been recently documented in aquatic systems. " | ( Chlorodifluoroacetic acid fate and toxicity to the macrophytes Lemna gibba, Myriophyllum spicatum, and Myriophyllum sibiricum in aquatic microcosms. Hanson, ML; Mabury, SA; Muir, DC; Sibley, PK; Solomon, KR, 2001) | 3.2 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 23.30
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.30) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |